收藏切换
Research on medication rules in high-dimensional clinical data based on deep clustering
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(5) : 1708 - 1716
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(5): 1708-1716
Research on medication rules in high-dimensional clinical data based on deep clustering
Full
DENG Yuanyuan1, YOU Haixin1, LIANG Yang1, LI Lisong1, LIU Jing1, ZENG Guang2, DING Changsong3,1
Affiliations
    1 School of Informatics, Hunan University of Chinese Medicine, Changsha 410208, China;
    2 College of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China;
    3 Hunan Laboratory of TCM Big Data Analysis, Changsha 410208, China
doi: 10.7501/j.issn.0253-2670.2025.05.020
Outline
收藏切换
Objective To develop a clinical medication pattern analysis model to identify potential medication patterns within multi-dimensional clinical data by utilizing the advantages of deep clustering in high-dimensional and complex data processing. Methods The real-world clinical stroke data were collected for screening and specification. Then, techniques such as graph convolutional neural networks, autoencoders, and self supervised mechanisms are used to construct a deep clustering model—multi-source fusion convolutional network (MFCN) for multi-source information fusion. The performance of the model was validated on two datasets, with the stroke dataset used as a case study to further analyze its clinical medication patterns and demonstrate the effectiveness of the model in mining high-dimensional clinical data. Results The accuracy of the MFCN model on the DBLP and stroke datasets were 79.32% and 83.48%, respectively. The normalized mutual information (NMI) indicators were 0.490 8 and 0.531 6, the average rand index (ARI) indicators were 0.541 9 and 0.581 7, and the F1-score (F1) indicators were 0.787 7 and 0.833 9, respectively. Its performance indicators were higher than those of other models. In the stroke dataset, the MFCN model successfully identified Chinese herbal combinations in the acute phase, such as licorice, Fuling (Poria), and Chenpi (Citri Reticulatae Pericarpium), and discovered “symptom-drug” associations, such as “Gancao (Glycyrrhizae Radix et Rhizoma)-mai xian”, “Glycyrrhizae Radix et Rhizoma-tongue red”, and “Chenpi (Citri Reticulatae Pericarpium)-limb weakness”. Conclusion Deep clustering can effectively handle complex high-dimensional clinical data and reveal potential patterns of clinical medication, with view to providing methodological references for extracting clinical experience and assisting decision-making.
stroke  /  deep clustering  /  medication rules  /  data mining  /  multi-source fusion convolutional network
邓媛媛, 游海心, 梁杨, 李力松, 刘静, 曾光, 丁长松. 基于深度聚类的高维临床数据用药规律研究. 中草药, 2025 , 56 (5) : 1708 -1716 . DOI: 10.7501/j.issn.0253-2670.2025.05.020
DENG Yuanyuan, YOU Haixin, LIANG Yang, LI Lisong, LIU Jing, ZENG Guang, DING Changsong. Research on medication rules in high-dimensional clinical data based on deep clustering[J]. Chinese Traditional and Herbal Drugs, 2025 , 56 (5) : 1708 -1716 . DOI: 10.7501/j.issn.0253-2670.2025.05.020
Year 2025 volume 56 Issue 5
41
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.05.020
  • Receive Date:2024-11-13
  • Online Date:2026-11-13
Article Data
Affiliations
History
  • Received:2024-11-13
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2025.05.020
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT